Back to results
CompletedPhase 1Phase 2

Study of CRLX101 (NLG207) in the Treatment of Advanced Solid Tumors

NCT00333502

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Virginia G. Piper Cancer Center

Scottsdale, Arizona, United States

+2 additional locations

View on ClinicalTrials.gov
Study of CRLX101 (NLG207) in the Treatment of Advanced Solid Tumors — TrialFind